Markets:

Overview

News

Currencies

International

Treasuries

Inovio Pharmaceuticals, Inc. - Common Stock (NQ:INO)

2.180 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EST, Dec 9, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Press Releases about Inovio Pharmaceuticals, Inc. - Common Stock

Avacta Appoints David Liebowitz, M.D., Ph.D. as Chief Medical Officer and Yulii Bogatyrenko as Advisor in Business Development

July 01, 2025

From AVACTA GROUP PLC

Via GlobeNewswire

Global Coronavirus Therapeutics Market Size Projected to Exceed $16 Billion By the End of 2031

September 04, 2024

EQNX::TICKER_START (NASDAQ:SBFM),(NASDAQ:MRNA),(NYSE:PFE),(NASDAQ:VIR),(NASDAQ:INO) EQNX::TICKER_END

Via FinancialNewsMedia

Global Coronavirus Therapeutics Market Size Projected to Exceed $16 Billion By the End of 2031

September 04, 2024

From FN Media Group LLC

Via GlobeNewswire

Novavax’s dispute resolution and upcoming earnings call

February 23, 2024

Novavax navigates legal settlements, earnings expectations, and competition, hoping their protein-based vaccines become a global health game-changer.

Via MarketBeat

Topics Earnings

INOVIO Announces Notice of Pendency and Proposed Settlement of Stockholder Derivative Actions

June 23, 2023

From Inovio Pharmaceuticals, Inc.

Via GlobeNewswire

Coronavirus Vaccine Market To Surpass $95 Billion By 2028

February 28, 2023

EQNX::TICKER_START (NASDAQ:SBFM),(NASDAQ:MRNA),(NASDAQ:NVAX),(NASDAQ:VIR),(NASDAQ:INO) EQNX::TICKER_END

Via FinancialNewsMedia

While COVID-19 Drags On, Biotechs Introduce New Treatments & Vaccines to Combat Subvariants

November 16, 2022

EQNX::TICKER_START (OTCQB:BIXT),(NASDAQ:NVAX),(NYSE:PFE),(NASDAQ:MRNA),(NASDAQ:INO),(NASDAQ:BNTX) EQNX::TICKER_END

Via FinancialNewsMedia

Two Appealing Biotech Stocks for Two Distinct investors

August 08, 2022

Investing in biotech stocks carries both risk and reward. This article highlights two biotech companies that may appeal to specific investing styles

Via MarketBeat

Topics Intellectual Property

Does Amarin Deserve a Spot in Your Portfolio after Earnings ?

August 04, 2022

Amarin recently announced its earnings for Q2'22 with mixed results. Here we'll examine the pros and cons of having this penny stock in your portfolio.

Via MarketBeat

Topics Earnings

Rising Test Accuracy Standards Needed as On-Site Demand for Covid-19 Testing Increases

November 09, 2021

FN Media Group Presents USA News Group News Commentary Vancouver, BC –November 9, 2021 – USA News Group – After the launch of US President Joe Biden’s pushing of mandatory vaccination/testing in the...

Via FinancialNewsMedia

New Covid-19 Vaccines Continue to Be Developed by Biotech Firms Seeking to Improve the Jab

October 06, 2021

FN Media Group Presents USA News Group News Commentary Vancouver, BC –October 6, 2021 – USA News Group – As vaccine passport programs continue to roll out in new markets across the globe, especially in...

Via FinancialNewsMedia

Growing Acceptance Of Digital Health Services is a Huge Boon for Healthcare Cloud Computing Market

January 20, 2022

Palm Beach, FL – January 20, 2022 – FinancialNewsMedia.com News Commentary – Cloud computing increases real-time data collection and improves accessibility to the data. It has outpaced the conventional...

Via FinancialNewsMedia

INOVIO INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Inovio Pharmaceuticals Inc. - INO

April 09, 2021

From Kahn Swick & Foti, LLC

Via Business Wire

Scientific Reports Revealing Early Promise for Universal Coronavirus Vaccine

October 20, 2021

Palm Beach, FL – October 20, 2021 – FinancialNewsMedia.com News Commentary – Recently, scientific reports have shown that a universal coronavirus vaccine that protects against COVID-19 causing...

Via FinancialNewsMedia

As the Virus Continues, the Global Covid-19 Vaccine Market Expected to Reach $25 Billion By 2024

September 23, 2021

Via FinancialNewsMedia

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.